MARCELA CASAS: Open Payments
NPI 1386311298 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,074 in 87 payments from 22 companies in 2025. Trend: 2023 $1,942 · 2024 $1,953 · 2025 $3,074
Food & beverage: $1,758Honoraria: $1,170Travel & lodging: $137Speaker / faculty: $9
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 22 | $1,621 |
| ABBVIE INC. | 17 | $334 |
| Neurocrine BioSciences, Inc. | 9 | $205 |
| Amneal Pharmaceuticals LLC | 10 | $190 |
| Neurelis, Inc. | 4 | $95 |
| UCB, Inc. | 2 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Eisai Inc. | 2 | $61 |
| Merz Pharmaceuticals, LLC | 2 | $58 |
| Lilly USA, LLC | 2 | $49 |
Products named: Gocovri, INGREZZA, CREXONT, QULIPTA, VALTOCO, VYALEV, AUSTEDO XR, Leqembi.
Industry payments across FL — which companies pay providers there.
